β2-microglobulin is a systemic pro-aging factor that impairs cognitive function and neurogenesis LK Smith, Y He, JS Park, G Bieri, CE Snethlage, K Lin, G Gontier, R Wabl, ... Nature medicine 21 (8), 932-937, 2015 | 498 | 2015 |
Neuronal O-GlcNAcylation improves cognitive function in the aged mouse brain EG Wheatley, E Albarran, CW White, G Bieri, C Sanchez-Diaz, K Pratt, ... Current Biology 29 (20), 3359-3369. e4, 2019 | 81 | 2019 |
Sofosbuvir protects human brain organoids against SARS-CoV-2 P Mesci, A Macia, A Saleh, L Martin-Sancho, X Yin, C Snethlage, ... BioRxiv, 2020.05. 30.125856, 2020 | 67 | 2020 |
Therapeutically viable generation of neurons with antisense oligonucleotide suppression of PTB R Maimon, C Chillon-Marinas, CE Snethlage, SM Singhal, ... Nature neuroscience 24 (8), 1089-1099, 2021 | 48 | 2021 |
SARS-CoV-2 infects human brain organoids causing cell death and loss of synapses that can be rescued by treatment with Sofosbuvir P Mesci, JS de Souza, L Martin-Sancho, A Macia, A Saleh, X Yin, ... PLoS biology 20 (11), e3001845, 2022 | 45 | 2022 |
CADM2 is implicated in impulsive personality and numerous other traits by genome- and phenome-wide association studies in humans and mice S Sanchez-Roige, MV Jennings, HHA Thorpe, JE Mallari, ... Translational psychiatry 13 (1), 167, 2023 | 33 | 2023 |
MHC class I H2-Kb negatively regulates neural progenitor cell proliferation by inhibiting FGFR signaling K Lin, G Bieri, G Gontier, S Müller, LK Smith, CE Snethlage, CW White III, ... PLoS biology 19 (6), e3001311, 2021 | 24 | 2021 |
Sofosbuvir protects human brain organoids against SARS-CoV-2. bioRxiv 2020.05. 30.125856 P Mesci, A Macia, A Saleh, L Martin-Sancho, X Yin, C Snethlage, ... Doi 10 (2020.05), 30.125856, 2020 | 10 | 2020 |
CADM2 is implicated in impulsive personality traits by genome-and phenome-wide association studies in humans, with further support from studies of Cadm2 mutant mice S Sanchez-Roige, MV Jennings, HHA Thorpe, JE Mallari, L Van der Werf, ... medRxiv, 2022.01. 29.22270095, 2022 | 7 | 2022 |
Human microglial cells as a therapeutic target in a neurodevelopmental disease model P Mesci, CN LaRock, JJ Jeziorski, H Nakashima, N Chermont, A Ferrasa, ... Stem Cell Reports 19 (8), 1074-1091, 2024 | 1 | 2024 |
CORTICAL BRAIN ORGANOIDS IN A ZERO GLUCOSE ENVIRONMENT, A STEP FURTHER INTO USING ORGANOIDS AS MODELS FOR NEONATAL HYPOGLYCEMIA L Forero, AE Lee, LM Bird, C Snethlage, A Gomes, A Muotri, B Barshop JOURNAL OF INVESTIGATIVE MEDICINE 71 (1), NP385-NP386, 2023 | | 2023 |
METABOLOMIC STUDIES IN CORTICAL BRAIN ORGANOIDS L Forero-Zapata, A Lee, A Muotri, C Snethlage, JA Gangoiti, BA Barshop Molecular Genetics and Metabolism 135 (4), 271, 2022 | | 2022 |
CALCULATION OF BRAIN ORGANOIDS GLUCOSE CONSUMPTION. A CRITICAL FIRST STEP IN UNDERSTANDING ORGANOID METABOLISM L Forero, AE Lee, LM Bird, C Snethlage, A Muotri JOURNAL OF INVESTIGATIVE MEDICINE 70 (1), 300-300, 2022 | | 2022 |